Dr. Meenu Walia

MBBS, MD (Internal Medicine), DNB (Medical Oncology)

Senior Director & Head – Department of Medical Oncology

28+ Years of Experience
Delhi NCR

Dr. Meenu Walia is a legendary pioneer, an absolute titan, and one of the most revered authorities in the global landscape of Medical Oncology. She holds the historic distinction of being the first woman in India to earn a formal DNB degree in Medical Oncology. Dr. Walia represents the absolute peak tier of evidence-based cancer management, precision therapeutics, and personalized oncology in South Asia. She is widely sought after by a vast multi-ethnic patient base for her elite expertise in constructing highly advanced chemotherapy lines, modern target-oriented biological therapies, and cutting-edge cancer immunotherapies. Known for her deeply intellectual mind, fierce ethical practice, and profoundly empathetic care lines, she designs comprehensive cancer-warrior strategies emphasizing long-term survival and optimal quality of life.

  • Solid Tumor Oncology: Advanced medical protocols and biological targeted lines for breast malignancies, lung cancers, gynecological tumors, and gastrointestinal cancers.

  • Precision Cancer Immunotherapy: Deploying modern checkpoint inhibitors and immune-modulators to train the body’s natural cells to target aggressive cancers.

  • Hematological Malignancies: Formulating intensive multi-drug systemic chemotherapies to treat adult leukemias, lymphomas, and multiple myelomas.

  • Personalized Targeted Therapies: Utilizing advanced genetic and molecular profiling of tumors to intercept cancer growth pathways at a cellular level.
  • Successfully guided tens of thousands of cancer warriors through complex, intense curative systemic therapeutic journeys with world-class survival outcomes.

  • Played a monumental, central role in designing and leading public cancer awareness campaigns, heavily focusing on early screening access across North India.

  • Prolific academic leader who has published numerous high-impact research papers in indexed international oncology journals and authored definitive public health modules.
  • Conferred with multiple prestigious Lifetime Achievement accolades, “Oncologist of the Year” honors, and corporate clinical leadership awards by national oncology assemblies.

  • Active member of elite global bodies including the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO).